Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-264-8 | CAS number: 30618-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Department of health of the government of the United Kingdom
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- At that time, no OECD guideline on LLNA method had been published.
Test material
- Reference substance name:
- Mercaptoacetic acid, monoester with propane-1,2,3-triol
- EC Number:
- 250-264-8
- EC Name:
- Mercaptoacetic acid, monoester with propane-1,2,3-triol
- Cas Number:
- 30618-84-9
- Molecular formula:
- C5H10O4S
- IUPAC Name:
- 2,3-dihydroxypropyl 2-sulfanylacetate
- Test material form:
- solid - liquid: suspension
- Details on test material:
- - Name of test material (as cited in study report): Glyceryl Thioglycolate 80 %
- Analytical purity: 80.2 %
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited, Burton-on-Trent, Staffordshire, UK
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 316 - 390 g
- Housing: Single or in pairs in solid-floor polypropylene cages furnished with woodflakes
- Diet: Ad libitum
- Water: Ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 22
- Humidity (%): 37 - 58
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- - Intradermal induction : 1% w/v of the supplied test material in distilled water
- Topical lnduction : 10% v/v of the supplied test material in distilled water
- Topical Challenge : 10% and 5% v/v of the supplied test material in distilled water
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- - Intradermal induction : 1% w/v of the supplied test material in distilled water
- Topical lnduction : 10% v/v of the supplied test material in distilled water
- Topical Challenge : 10% and 5% v/v of the supplied test material in distilled water
- No. of animals per dose:
- Twenty test (10 male, 10 female) and ten control animals (5 male, 5 female)
- Details on study design:
- RANGE FINDING TESTS:
- The highest concentration that caused only mild to moderate skin irritation, and which was well tolerated systemically, was selected for the intradermal induction stage of the main study.
- The highest concentration producing only mild to moderate dermal irritation was selected for the TOPICAL induction stage of the main study.
- The highest non-irritant concentration of the test material and one lower concentration were selected for the topical challenge stage of the main study.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Intradermal and topical induction
- Intradermal: 3 single Injections: a) Freund’s Complete Adjuvant plus distilled water in the ratio 1:1
b) a 1% w/v formulation of the supplied test material in distilled water
c) a 1% w/v formulation of the supplied test material in a 1:1 preparation of Freund’s Complete Adjuvant in distilled water
- Topical induction: 7 days after intradermal induction: Occlusive dressing with 10% v/v in distilled water for 48 h
- Control animals where treated in the same manner with vehicle instead of test material
- As the test material showed evidence for skin irritation, no local irritation by sodium lauryl sulphate was created.
B. CHALLENGE EXPOSURE
- Exposure period: 24 h
- Test groups: 5 and 10% v/v of the supplied test material in distilled water
- Control group: Vehicle
- Evaluation (hr after challenge): Approximately 24, 48 and 72 hours after challenge dressing removal, the degree of erythema and oedema was quantified.
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 % v/v
- No. with + reactions:
- 9
- Total no. in group:
- 20
- Clinical observations:
- erythema and oedema formation up to score of 2
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10 % v/v. No with. + reactions: 9.0. Total no. in groups: 20.0. Clinical observations: erythema and oedema formation up to score of 2.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 10% v/v. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 % v/v
- No. with + reactions:
- 10
- Total no. in group:
- 20
- Clinical observations:
- erythema and oedema formation up to score of 2, desquamation
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10 % v/v. No with. + reactions: 10.0. Total no. in groups: 20.0. Clinical observations: erythema and oedema formation up to score of 2, desquamation.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10% v/v
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Clinical observations:
- no erythema or edema, only slight desquamation
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10% v/v. No with. + reactions: 5.0. Total no. in groups: 10.0. Clinical observations: no erythema or edema, only slight desquamation.
Any other information on results incl. tables
INDIVIDUAL SKIN REACTIONS AT TEST ANIMALS AT CHALLENGE
|
24 h first reading |
48 h second reading |
72 h third reading |
|||||||||||||||
|
5 % |
10% |
5 % |
10% |
5 % |
10% |
||||||||||||
Animal |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
1 |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
* |
2 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
3 |
1 |
0 |
- |
1 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
- |
0 |
0 |
D |
4 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
5 |
1 |
1 |
- |
2 |
1 |
- |
1 |
0 |
- |
0 |
1 |
- |
0 |
0 |
- |
1 |
0 |
D |
6 |
1 |
1 |
- |
2 |
1 |
- |
1 |
1 |
- |
2 |
1 |
D |
0 |
0 |
D |
0 |
0 |
D |
7 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
D |
0 |
0 |
D |
0 |
0 |
D |
8 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
9 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
10 |
1 |
0 |
- |
2 |
1 |
- |
0 |
0 |
- |
1 |
1 |
D |
0 |
0 |
D |
0 |
0 |
D |
11 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
1 |
1 |
- |
12 |
1 |
1 |
- |
1 |
1 |
- |
1 |
0 |
- |
1 |
1 |
D |
0 |
0 |
D |
0 |
0 |
D |
13 |
1 |
1 |
- |
1 |
1 |
- |
1 |
0 |
- |
1 |
1 |
- |
0 |
0 |
D |
0 |
0 |
D |
14 |
0 |
0 |
- |
1 |
1 |
- |
0 |
0 |
- |
2 |
1 |
- |
0 |
0 |
- |
0 |
0 |
D |
15 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
16 |
0 |
0 |
- |
0 |
0 |
- |
# |
# |
# |
# |
# |
# |
# |
# |
# |
# |
# |
# |
17 |
1 |
1 |
- |
2 |
2 |
- |
1 |
1 |
D |
2 |
2 |
D |
0 |
0 |
D |
0 |
0 |
D |
18 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
19 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
1 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
20 |
1 |
1 |
- |
1 |
1 |
- |
1 |
1 |
D |
1 |
0 |
- |
0 |
0 |
D |
0 |
0 |
D |
Er = Erythema, Oe = Oedema, - = no other reactions noted, D = desquamation, * = no data; animal killed for humane reasons on Day 20, # = no data; animal found dead on Day 24
INDIVIDUAL SKIN REACTIONS AT CONTROL ANIMALS AT CHALLENGE
|
24 h first reading |
48 h second reading |
72 h third reading |
|||||||||||||||
|
5 % |
10% |
5 % |
10% |
5 % |
10% |
||||||||||||
Animal |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
Er |
Oe |
Other |
21 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
- |
22 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
D |
0 |
0 |
D |
23 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
24 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
- |
0 |
0 |
D |
25 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
D |
0 |
0 |
D |
26 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
- |
0 |
0 |
D |
27 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
28 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
0 |
0 |
- |
0 |
0 |
D |
29 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
30 |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
- |
0 |
0 |
D |
Er = Erythema, Oe = Oedema, - = no other reactions noted, D = desquamation,
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- GMT is a moderate sensitizer to guinea pig skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.